These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6379046)

  • 1. Differences in delayed-type hypersensitivity responses in various mouse strains in the C3H lineage infected with Salmonella typhimurium, strain SL3235.
    Killar LM; Eisenstein TK
    J Immunol; 1984 Sep; 133(3):1190-6. PubMed ID: 6379046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed-type hypersensitivity and immunity to Salmonella typhimurium.
    Killar LM; Eisenstein TK
    Infect Immun; 1986 May; 52(2):504-8. PubMed ID: 3516875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression induced by attenuated Salmonella: effect of LPS responsiveness on development of suppression.
    al-Ramadi BK; Greene JM; Meissler JJ; Eisenstein TK
    Microb Pathog; 1992 Apr; 12(4):267-78. PubMed ID: 1630297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine.
    Killar LM; Eisenstein TK
    Infect Immun; 1985 Mar; 47(3):605-12. PubMed ID: 3882560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain dependent variation of delayed-type hypersensitivity in Salmonella typhimurium infected mice.
    Killar L; Eisenstein TK
    Adv Exp Med Biol; 1983; 162():297-302. PubMed ID: 6346823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
    J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice.
    Eisenstein TK; Killar LM; Stocker BA; Sultzer BM
    J Immunol; 1984 Aug; 133(2):958-61. PubMed ID: 6376631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immunity to Salmonella typhimurium and delayed (footpad) hypersensitivity in BALB/c mice.
    Hormaeche CE; Fahrenkrog MC; Pettifor RA; Brock J
    Immunology; 1981 Jul; 43(3):547-54. PubMed ID: 7019057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections.
    Hagberg L; Briles DE; Edén CS
    J Immunol; 1985 Jun; 134(6):4118-22. PubMed ID: 3886795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimurium.
    Lee JC; Gibson CW; Eisenstein TK
    Cell Immunol; 1985 Mar; 91(1):75-91. PubMed ID: 3882246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural resistance to Salmonella typhimurium in different inbred mouse strains.
    Hormaeche CE
    Immunology; 1979 Jun; 37(2):311-8. PubMed ID: 381178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection.
    Eisenstein TK; Killar LM; Sultzer BM
    J Infect Dis; 1984 Sep; 150(3):425-35. PubMed ID: 6207248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Pneumocystis carinii pneumonia in C3H/HeJ and C3HeB/FeJ mice.
    Walzer PD; Rutledge ME; Yoneda K
    J Reticuloendothel Soc; 1983 Jan; 33(1):1-9. PubMed ID: 6601189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic response of splenectomized C3HeB/FeJ and C3H/HeJ mice to lipopolysaccharide.
    MacVittie TJ; Weinberg SR
    Exp Hematol; 1981 Oct; 9(9):950-5. PubMed ID: 7338273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in mice.
    Tagliabue A; Nencioni L; Villa L; Boraschi D
    Clin Exp Immunol; 1984 Jun; 56(3):531-6. PubMed ID: 6378451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriological and immunological aspects of conventional and germfree mice infected with Salmonella typhimurium.
    Nardi RM; Vieira EC; Crocco-Afonso LC; Silva ME; Bambirra EA; Andrade AM; Nicoli JR
    Rev Latinoam Microbiol; 1991; 33(4):239-43. PubMed ID: 1670260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFNγ expression by an attenuated strain of Salmonella enterica serovar Typhimurium improves vaccine efficacy in susceptible TLR4-defective C3H/HeJ mice.
    Al-Ojali SM; Tara Moore CB; Fernandez-Cabezudo MJ; Al-Ramadi BK
    Med Microbiol Immunol; 2013 Feb; 202(1):49-61. PubMed ID: 22684724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ity influences the production of IFN-gamma by murine splenocytes stimulated in vitro with Salmonella typhimurium.
    Ramarathinam L; Niesel DW; Klimpel GR
    J Immunol; 1993 May; 150(9):3965-72. PubMed ID: 8473743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective capacity of L-form Salmonella typhimurium against murine typhoid in C3H/HeJ mice.
    Nishikawa F; Kita E; Yamada H; Nakano A; Kashiba S
    Microbiol Immunol; 1994; 38(2):129-37. PubMed ID: 8041300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.